About PhRMA
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are laser focused on developing innovative medicines that transform lives and create a healthier world. Together, we are fighting for solutions to ensure patients can access and afford medicines that prevent, treat and cure disease. Over the last decade, PhRMA member companies have invested more than $850 billion in the search for new treatments and cures, and they support nearly five million jobs in the United States.
Connect with PhRMA
For information on how innovative medicines save lives, please visit:
www.PhRMA.org
www.VotersforCures.org
www.AmericasMedicines.com
www.Facebook.com/PhRMA
www.X.com/PhRMA
This list includes innovative contracts executed and publicly announced in the United States from 2009-2021. This list includes public program innovative contracts to the extent that they are modeled similarly to commercial contracts, but does not include other public program contracts that may be seen as types of innovative contracts (e.g., Coverage with Evidence Development). This list is not comprehensive; we believe evidence suggests many innovative contracts are executed without the release of publicly available information.
Innovative Contracts 2009 - 2021 image
Fact Sheet
Cost and Value
Innovative Contracts 2009 - 2021
Innovative Contracts 2009 - 2021 image